Phenanthridinones as parp inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050171101A1
SERIAL NO

10508004

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound of the formula (I): wherein ring A is a carbocyclic group, R1 is hydrogen or a halogen atom or a lower alkyl group, R2 is a di(lower)alkylamino group or N-containing heterocyclic group, among which the N-containing heterocyclic group may be substituted with one or more substituent(s), Y is an oxygen or sulfur atom, n is an integer from 0 to 2, and m is an integer from 0 to 4, or its prodrug, or their salt which has poly(adenosine 5'-diphospho-ribose)polymerase inhibiting activity. 1

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FUJISAWA PHARMACEUTICAL CO LTDOSAKA JAPAN OSAKA-SHI OSAKA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hattori, Kouji Osaka, JP 25 358
Mukoyoshi, Koichiro Osaka, JP 10 315
Yamamoto, Hirofumi Osaka, JP 141 760

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation